Multiple randomized clinical trials and analyses of electronic health records (EHRs) suggest that metformin, a widely available diabetes drug, may reduce the risk of developing long COVID when taken during or shortly after acute COVID-19…
Continue Reading
News Source: www.cidrap.umn.edu

Leave a Reply